HEADER LIPID BINDING PROTEIN 09-JUN-18 6DO7 TITLE NMR SOLUTION STRUCTURE OF WILD TYPE HFABP1 WITH GW7647 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FATTY ACID-BINDING PROTEIN, LIVER; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FATTY ACID-BINDING PROTEIN 1,LIVER-TYPE FATTY ACID-BINDING COMPND 5 PROTEIN,L-FABP; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FABP1, FABPL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LIPID BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR M.J.SCANLON,B.MOHANTY,B.C.DOAK,R.PATIL REVDAT 5 01-MAY-24 6DO7 1 REMARK REVDAT 4 01-JAN-20 6DO7 1 REMARK REVDAT 3 20-MAR-19 6DO7 1 JRNL REVDAT 2 09-JAN-19 6DO7 1 JRNL REVDAT 1 02-JAN-19 6DO7 0 JRNL AUTH R.PATIL,B.MOHANTY,B.LIU,I.R.CHANDRASHEKARAN,S.J.HEADEY, JRNL AUTH 2 M.L.WILLIAMS,C.S.CLEMENTS,O.ILYICHOVA,B.C.DOAK,P.GENISSEL, JRNL AUTH 3 R.J.WEAVER,L.VUILLARD,M.L.HALLS,C.J.H.PORTER,M.J.SCANLON JRNL TITL A LIGAND-INDUCED STRUCTURAL CHANGE IN FATTY ACID-BINDING JRNL TITL 2 PROTEIN 1 IS ASSOCIATED WITH POTENTIATION OF PEROXISOME JRNL TITL 3 PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONISTS. JRNL REF J. BIOL. CHEM. V. 294 3720 2019 JRNL REFN ESSN 1083-351X JRNL PMID 30598509 JRNL DOI 10.1074/JBC.RA118.006848 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : OPALP, PRIME REMARK 3 AUTHORS : KORADI ET AL, 2000 (OPALP), PRIME, SCHRODINGER, REMARK 3 LLC, NEW YORK, NY, 2018 (PRIME) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL OF REMARK 3 2553 NOE-DERIVED DISTANCE CONSTRAINTS, 202 DIHEDRAL ANGLE REMARK 3 CONSTRAINTS, 58 DISTANCE RESTRAINTS FROM HYDROGEN BONDS REMARK 4 REMARK 4 6DO7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1000234246. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : 20 MM SODIUM PHOSPHATE, 50 MM REMARK 210 NACL REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 20 MM SODIUM PHOSPHATE, 50 MM REMARK 210 SODIUM CHLORIDE, 0.5 MM [U-13C; REMARK 210 U-15N] HUMAN LIVER FATTY ACID REMARK 210 BINDING PROTEIN (HFABP1), 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 3D HNCA; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D 15N RESOLVED [1H, REMARK 210 1H]-NOESY; 3D 13CALIPHATIC REMARK 210 RESOLVED [1H,1H]-NOESY; 3D REMARK 210 13CAROMATIC RESOLVED [1H,1H]- REMARK 210 NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, CARA, CYANA, UNIO10 REMARK 210 -ATNOS/CANID 2.0.2 REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 40 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH ACCEPTABLE REMARK 210 COVALENT GEOMETRY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A -4 76.90 66.94 REMARK 500 1 MET A 1 145.50 70.44 REMARK 500 1 SER A 56 -30.68 -158.22 REMARK 500 1 CYS A 69 -162.91 -125.18 REMARK 500 1 PHE A 95 -85.43 -133.85 REMARK 500 1 LYS A 96 -51.76 -122.01 REMARK 500 1 ASN A 97 12.87 -145.60 REMARK 500 2 HIS A -5 -56.62 -170.64 REMARK 500 2 ALA A 0 149.44 -171.17 REMARK 500 2 ASN A 44 54.83 -117.45 REMARK 500 2 SER A 56 34.20 -147.79 REMARK 500 2 ASP A 88 48.14 -143.43 REMARK 500 2 LYS A 96 -101.71 -149.26 REMARK 500 3 HIS A -6 -43.26 -170.56 REMARK 500 3 HIS A -2 -12.85 -170.06 REMARK 500 3 MET A 1 -175.62 64.12 REMARK 500 3 SER A 2 136.35 -173.23 REMARK 500 3 SER A 56 46.84 -162.11 REMARK 500 3 ASP A 88 57.36 -151.26 REMARK 500 3 PHE A 95 -56.81 -127.71 REMARK 500 3 LYS A 96 -63.10 -140.62 REMARK 500 4 HIS A -2 -32.12 -158.52 REMARK 500 4 GLN A 10 -60.63 -120.39 REMARK 500 4 PHE A 95 -87.74 -79.54 REMARK 500 4 ASN A 97 26.50 -157.22 REMARK 500 5 HIS A -2 36.31 -82.59 REMARK 500 5 MET A 1 -169.53 64.92 REMARK 500 5 PHE A 3 46.24 -78.38 REMARK 500 5 GLN A 10 -67.86 -102.48 REMARK 500 5 ALA A 54 -145.96 -113.13 REMARK 500 5 SER A 56 -62.03 -140.90 REMARK 500 5 PHE A 95 -76.38 -139.30 REMARK 500 5 LYS A 96 -50.20 -133.40 REMARK 500 6 HIS A -6 19.63 -174.71 REMARK 500 6 HIS A -4 -87.71 -135.05 REMARK 500 6 SER A 56 39.05 -149.66 REMARK 500 6 PHE A 95 -55.02 -143.53 REMARK 500 6 LYS A 96 -54.22 -157.02 REMARK 500 7 HIS A -5 -55.73 -158.59 REMARK 500 7 HIS A -4 -15.68 68.32 REMARK 500 7 ALA A 0 177.26 67.79 REMARK 500 7 GLN A 10 -61.38 -103.57 REMARK 500 7 ALA A 54 -152.32 -98.64 REMARK 500 7 SER A 56 9.30 -157.93 REMARK 500 7 LYS A 96 -61.59 -145.97 REMARK 500 8 HIS A -5 79.75 -159.20 REMARK 500 8 HIS A -3 -66.51 -105.23 REMARK 500 8 HIS A -2 84.49 -152.07 REMARK 500 8 VAL A -1 -52.70 -155.95 REMARK 500 8 ALA A 0 165.53 61.32 REMARK 500 REMARK 500 THIS ENTRY HAS 64 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30478 RELATED DB: BMRB REMARK 900 NMR SOLUTION STRUCTURE OF WILD TYPE HFABP1 IN THE PRESENCE OF GW7647 DBREF 6DO7 A 1 127 UNP P07148 FABPL_HUMAN 1 127 SEQADV 6DO7 HIS A -7 UNP P07148 EXPRESSION TAG SEQADV 6DO7 HIS A -6 UNP P07148 EXPRESSION TAG SEQADV 6DO7 HIS A -5 UNP P07148 EXPRESSION TAG SEQADV 6DO7 HIS A -4 UNP P07148 EXPRESSION TAG SEQADV 6DO7 HIS A -3 UNP P07148 EXPRESSION TAG SEQADV 6DO7 HIS A -2 UNP P07148 EXPRESSION TAG SEQADV 6DO7 VAL A -1 UNP P07148 EXPRESSION TAG SEQADV 6DO7 ALA A 0 UNP P07148 EXPRESSION TAG SEQRES 1 A 135 HIS HIS HIS HIS HIS HIS VAL ALA MET SER PHE SER GLY SEQRES 2 A 135 LYS TYR GLN LEU GLN SER GLN GLU ASN PHE GLU ALA PHE SEQRES 3 A 135 MET LYS ALA ILE GLY LEU PRO GLU GLU LEU ILE GLN LYS SEQRES 4 A 135 GLY LYS ASP ILE LYS GLY VAL SER GLU ILE VAL GLN ASN SEQRES 5 A 135 GLY LYS HIS PHE LYS PHE THR ILE THR ALA GLY SER LYS SEQRES 6 A 135 VAL ILE GLN ASN GLU PHE THR VAL GLY GLU GLU CYS GLU SEQRES 7 A 135 LEU GLU THR MET THR GLY GLU LYS VAL LYS THR VAL VAL SEQRES 8 A 135 GLN LEU GLU GLY ASP ASN LYS LEU VAL THR THR PHE LYS SEQRES 9 A 135 ASN ILE LYS SER VAL THR GLU LEU ASN GLY ASP ILE ILE SEQRES 10 A 135 THR ASN THR MET THR LEU GLY ASP ILE VAL PHE LYS ARG SEQRES 11 A 135 ILE SER LYS ARG ILE HELIX 1 AA1 ASN A 14 ILE A 22 1 9 HELIX 2 AA2 PRO A 25 ILE A 35 1 11 SHEET 1 AA1 9 VAL A 58 THR A 64 0 SHEET 2 AA1 9 HIS A 47 THR A 53 -1 N PHE A 48 O PHE A 63 SHEET 3 AA1 9 VAL A 38 ASN A 44 -1 N GLU A 40 O THR A 51 SHEET 4 AA1 9 GLY A 5 GLU A 13 -1 N TYR A 7 O SER A 39 SHEET 5 AA1 9 ILE A 118 ARG A 126 -1 O ILE A 123 N SER A 11 SHEET 6 AA1 9 ILE A 108 LEU A 115 -1 N MET A 113 O PHE A 120 SHEET 7 AA1 9 ILE A 98 ASN A 105 -1 N ASN A 105 O ILE A 108 SHEET 8 AA1 9 LYS A 90 THR A 94 -1 N THR A 93 O SER A 100 SHEET 9 AA1 9 GLN A 84 LEU A 85 -1 N GLN A 84 O VAL A 92 SHEET 1 AA2 2 CYS A 69 GLU A 72 0 SHEET 2 AA2 2 LYS A 78 THR A 81 -1 O VAL A 79 N LEU A 71 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1